Journey Medical Corporation announced that the Company has entered into a credit facility with an affiliate of SWK Holdings Corporation providing for borrowings of up to $20 million. The Credit Facility provides for an initial term loan of $15 million that the Company intends to use to fund general corporate operations and commercial and DFD-29 product development initiatives. The Company also has the option to draw an additional tranche of $5 million under the Credit Facility, subject to the achievement of specified operational and financial metrics, in the twelve months following the date of the credit facility.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.7 USD | +0.43% | +20.51% | -18.40% |
May. 13 | Transcript : Journey Medical Corporation, Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Journey Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.40% | 94.06M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.83% | 248B | |
-1.55% | 219B | |
+11.08% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- DERM Stock
- News Journey Medical Corporation
- Journey Medical Corporation Secures Credit Facility with SWK Holdings for Up to $20 Million